1. P1714: HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH LIGHT CHAIN AMYLOIDOSIS IN EUROPE. (23rd June 2022) Authors: Jaccard, A.; Bridoux, F.; Roeloffzen, W.; Minnema, M. C.; Bergantim, R.; Hájek, R.; João, C.; Cibeira, M. T.; Palladini, G.; Schönland, S.; Merlini, G.; Milani, P.; Dimopoulos, M. A.; Ravichandran, S.; Hegenbart, U.; Agis, H.; Gros, B.; Asra, A.; Dergarabetian, E.; Magarotto, V. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P914: EFFICACY AND SAFETY OF BELANTAMAB MAFODOTIN MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK. (23rd June 2022) Authors: Kastritis, E.; Palladini, G.; Dimopoulos, M. A.; Jaccard, A.; Merlini, G.; Theodorakakou, F.; Fotiou, D.; Minnema, M. C.; Wechalekar, A.; Gkolfinopoulos, S.; Manousou, K.; Sonneveld, P.; Schönland, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 804 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P957: CARFILZOMIB, LENALIDOMIDE, DEXAMETHASONE FOLLOWED BY A SECOND AUTO-HCT IS AN EFFECTIVE STRATEGY IN FIRST RELAPSE MULTIPLE MYELOMA: A STUDY OF THE CHRONIC MALIGNANCIES WORKING PARTY OF EBMT. (23rd June 2022) Authors: Tilmont, R.; Yakoub-Agha, I.; Eikema, D.-J.; Zinger, N.; Haenel, M.; Schaap, N.; Herrera Arroyo, C.; Schuermans, C.; Bethge, W.; Engelhardt, M.; Kuball, J.; Michieli, M.; Schub, N.; Wilson, K. M. O.; Bourhis, J. H.; Mateos, M. V.; Robin, N.; Jost, E.; Kröger, N.; Moraleda, J. M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 847 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗